Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

80 trials with published results (18%)

Research Maturity

318 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

23 terminated out of 442 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

29%

128 trials in Phase 3/4

Results Transparency

25%

80 of 318 completed with results

Key Signals

80 with results93% success23 terminated

Data Visualizations

Phase Distribution

362Total
Not Applicable (132)
Early P 1 (1)
P 1 (53)
P 2 (48)
P 3 (78)
P 4 (50)

Trial Status

Completed318
Unknown37
Terminated23
Recruiting20
Not Yet Recruiting20
Withdrawn11

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 318 completed trials

Clinical Trials (442)

Showing 20 of 20 trials
NCT07515573Not ApplicableNot Yet RecruitingPrimary

Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals

NCT07238556Not ApplicableRecruiting

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

NCT07502703Not Yet RecruitingPrimary

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community

NCT07423884Not ApplicableNot Yet Recruiting

Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals

NCT07524101Not ApplicableNot Yet Recruiting

Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD

NCT07340580Not ApplicableNot Yet Recruiting

Implementation Facilitation of Exercise is Medicine Greenville

NCT06980428Phase 1Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

NCT06676046RecruitingPrimary

Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions

NCT07476248Not Yet Recruiting

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

NCT06784349Phase 1CompletedPrimary

ALN-APOC3 in Adult Participants With Dyslipidemia

NCT00001154Completed

Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins

NCT07447362Not ApplicableRecruiting

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

NCT06284681Not ApplicableCompleted

Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults

NCT07310849Not ApplicableEnrolling By Invitation

Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity

NCT07412457Not Yet RecruitingPrimary

Guideline Adherence in Dyslipidemia With Clinical Decision Support

NCT06832371Active Not Recruiting

Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

NCT07401017Not ApplicableNot Yet RecruitingPrimary

The Effects of Rosuvastatin on Running Training Adaptation and Safety

NCT06771024Not ApplicableNot Yet Recruiting

Community Physical Exercise Program in Chronic Disease

NCT07387393Not ApplicableNot Yet Recruiting

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

NCT07000825Not ApplicableEnrolling By Invitation

EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS

Scroll to load more

Research Network

Activity Timeline